A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus

Nature Medicine

Volumn 7, Issue 11, 2001, Pages 1189-1193

  Degiorgio, Lorraine A ^a,b,c   Konstantinov, Konstantin N ^b   Lee, Sunhee C ^c,d   Hardin, John A ^d   Volpe, Bruce T ^c   Diamond, Betty ^c,d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b LAD   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d KNK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA ANTIBODY; DOUBLE STRANDED DNA; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PENTAPEPTIDE; RECEPTOR SUBUNIT;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ANTIGEN BINDING; APOPTOSIS; ARTICLE; CELL DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CROSS REACTION; HUMAN; IMMUNOPATHOGENESIS; MALE; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; APOPTOSIS; CELLS, CULTURED; CROSS REACTIONS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, INBRED C57BL; NEURONS; RECEPTORS, N-METHYL-D-ASPARTATE;

ANIMALIA; MURINAE;

EID: 0035173156     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1101-1189     Document Type: Article

References (49)

1. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease
2. Magnetic resonance imaging of the brain in systemic lupus erythematosus
3. Anti-histone reactivity in systemic lupus erythematosus sera: A disease activity index linked to the presence of DNA: Anti-DNA immune complexes
4. Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus
5. Studies on the structure, regulation and pathogenic potential of anti-dsDNA antibodies
6. Molecular mimicry between bacterial and self Ag in a patient with systemic lupus erythematosus
7. Cross reactive antibodies have both protective and pathogenic potential
8. Endothelial cell binding by human polyclonal anti-DNA antibodies: Relationship to disease activity and endothelial functional alterations
9. Presence of antibodies against a cell-surface protein, cross-reactive with DNA, in systemic lupus erythematosus: A marker of the disease
10. Glycosaminoglycan in autoimmunity
11. Mutational analysis of an autoantibody: Differential binding and pathogenicity
12. An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with systemic lupus erythematosus
13. Peptide inhibition of glomerular deposition of an pathogenic anti-DNA antibody: Implications for therapy
14. Immunization with a peptide surrogate for dsDNA induces autoantibody production and renal immunoglobulin deposition
15. Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat
16. Expression of N-methyl 1-D-aspartate receptor subunit mRNAs in the human brain: Hippocampus and cortex
17. Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: Striatum and globus pallidus
18. Expression of NMDA receptor subunit mRNAs in neuro-chemically identified projection and interneurons in the human striatum
19. Glutamate receptors in the mammalian central nervous system
20. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor & 1 subunit
21. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5
22. The role of glutamate neurotoxicity in hypoxicischemic neuronal death
23. Calcium signaling in the ER: Its role in neuronal plasticity and neurodegenerative disorders
24. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics
25. Recent advances in the phencyclidine model of schizophrenia
26. NMDA receptor hypo function model of schizophrenia
27. The neuropsychopharmacology of phencyclidine: From NMDA receptor hypo function to the dopamine hypothesis of schizophrenia
28. Delayed neuronal degeneration results from endogenous glutamate excess: Possible role in "Neuro-SLE"
29. Characterization of the effects of polyamines on 1251 MK-801 binding to recombinant N-methyl-D-aspartate receptors
30. NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology
31. Antibodies reactive with central nervous system antigens
32. Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers
33. Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein
34. Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus
35. Autoimmunity and neurological disease: Antibody modulation of synaptic transmission
36. Glutamate receptor GluR 3 antibodies and death of cortical cells
37. GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins
38. Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation
39. The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia
40. Identification of autoantibodies associated with myelin damage in multiple sclerosis
41. Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis
42. Clinical studies on the significances of DNA: Anti-DNA complexes in the systemic circulation and cerebrospinal fluid (CSF) of patients with systemic lupus erythematosus
43. Glutamate signalling in non-neuronal tissues
44. Glutamate antagonists: Deadly liaisons with cancer
45. The 1982 revised criteria for the classification of systemic lupus erythematosus
46. BDNF prevents the loss of nigral neurons induced by excitotoxic striatal lesions
47. Neurotoxic APP C-terminal and β-amyloid domains co-localize in the nuclei of substantia nigra pars reticulata neurons
48. MK-801 but not NBQX prevents transneuronal degeneration of nigra neurons after neurotoxic striatal lesion
49. Neuronal death in cytokine-activated primary human brain cell culture: Role of tumor necrosis factor-α